COMP <GO>
PCVX vs TWST // FREE CASH FLOW YIELD
Vaxcyte Inc. (NASDAQ) VS. Twist Bioscience Corporation (NASDAQ) • 15-METRIC TALLY: PCVX 4
— TWST 7
▲ FREE CASH FLOW YIELD LEADER: TWST
LAST: $60.62 (-2.27%) • MKT CAP: $9.76B
fcf-yield
-6.79%
LAST: $129.04 (-15.54%) • MKT CAP: $10.13B
fcf-yield
-0.66%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PCVX VS. TWST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PCVX | TWST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 94.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.60% | -11.70% | -15.90 | TWST | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -6.79% | -0.66% | -6.13 | TWST | /fcf-yield <GO> |
| Operating Margin | -33.50% | -4.20% | -29.30 | TWST | /operating-margins <GO> |
| Net Profit Margin | 0.00% | -2.40% | +2.40 | PCVX | /net-margins <GO> |
| Revenue Growth (YoY) | 19.80% | 16.50% | +3.30 | PCVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 18.11 | 26.00 | -7.89 | TWST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | TWST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.7 | 48.4 | +0.30 | PCVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.98 | +0.09 | PCVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 21.0x | +2.00 | TWST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.76B | $10.13B | -$366.6M | TWST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PCVX REV | TWST REV | PCVX GROSS % | TWST GROSS % | PCVX FCF | TWST FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.59B | $381.5M | — | — | -$669.3M | -$75.6M |
| FY 2024 | $1.59B | $618.3M | — | — | -$475.1M | -$69.2M |
| FY 2023 | $1.31B | $608.0M | — | — | -$296.8M | -$142.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PCVX // BETA 1.07
TWST // BETA 0.98